University of Utah
Pediatric Oncologist and Medical Director
University of Utah, Salt Lake City, Utah, United States, 84193
Position Information
Position/Rank Pediatric Oncologist and Medical Director/Rank Dependent on Qualifications
Department 00857 - Pediatric Hematology/Oncology
City Salt Lake City, UT
Track Track Dependent on Qualifications
New Position to Begin CY2022 or later
Details
This is an outstanding opportunity to join a collegial academic environment at Primary Children’s Hospital ( PCH ) and the University of Utah with a childhood blood disorder and cancer program that U.S. News ranks among the top 20 in the nation. The Division of Pediatric Hematology Oncology, in the Department of Pediatrics, University of Utah School of Medicine, has an immediate opening for a board-certified Pediatric Hematologist/Oncologist, who will serve as the Medical Director of the Pediatric Hematopoietic Stem Cell Transplant and Cellular Therapy Program. This is an academic clinical leadership position with day-to-day responsibility for the operation of a busy clinical service. As a member of the division’s leadership team, the Director will lead a multidisciplinary team of pediatric hematology-oncology transplant and cellular therapy professionals managing blood disorders and cancer at PCH in the Pediatric Hematology/Oncology Service Line outpatient and inpatient units. The pediatric BMT physicians provide care to pediatric bone marrow transplant patients starting with initial consultation, preparation for and performance of the transplant process, and post-transplant care, including long-term follow-up. Clinical activities will be carried out at PCH . Active clinical programs include cellular and immune therapies and transplantation for hematologic malignancies, selected solid tumors, non-malignant disorders including bone marrow failure syndromes, immunodeficiencies, metabolic disorders and hemoglobinopathies. The BMT program directs an immune deficiency clinic that provides consultations, evaluations, and care to patients with immunodeficiencies. Active areas of research in the program include novel immune and cellular therapies, graft versus host disease, immunodeficiencies, and alternative stem cell transplants.
The Service-Line includes multi-disciplinary colleagues and investigators in Pediatric Hematology/Oncology, Transplantation and Cellular Therapy, and Radiation Oncology, along with additional services at the Huntsman Cancer Institute ( HCI ) and within the Department of Pediatrics. The Director will oversee and provide leadership in clinical, basic, and translational research programs, and will have the opportunity to implement early phase and investigator initiated clinical trials, as well as collaborations with established immunotherapy and cell therapy programs. The Director will also provide clinical patient care services. In addition to clinical service and research activities, there is an expectation for academic work, including education, investigation, administration, and advocacy.
This growing division is made up of more than 20 pediatric oncologists, including 4 pediatric BMT attendings, and 3 PhD investigators. In partnership with Pediatrics and PCH , the pediatric cancer research program at HCI is actively recruiting research scientists. The program has focused expertise in Oncology, Hematology, Transplantation and Cellular Therapy, Population Sciences, Cancer Control, and Pediatric Cancer Genetics. The program sees over 220 newly diagnosed children annually. It has consistently been in the top 10 enrolling COG institutions and is an active member of other national consortiums including PEP - CTN , PTCTC , TACL , POETIC , NANT , PNOC , and the Sunshine Network. The division houses the only pediatric BMT service in the Intermountain West, performs over 50 transplants annually, and has an active CAR T cell program. The Oncology section is made up of 14 physicians with varying levels of clinical, research, and programmatic leadership responsibility in the areas of leukemia/lymphoma, neuro-oncology, blastomas, and sarcomas. The inpatient unit has 33 private patient rooms where all hematology/oncology patients are admitted. Inpatients are overseen by 3 hematology/oncology services: an inpatient attending/resident/fellow hematology/oncology service, a chemotherapy attending/advanced practitioner service, and a BMT service with advanced practitioner support. All medical, pathology, radiologic and surgical subspecialties are represented in the children’s hospital.
PCH is ranked by US News in the top 20 childhood cancer programs, and provides care to children with cancer across the five-state Intermountain West region. The Department of Pediatrics ranks within the top 15 Pediatric Departments in NIH funding and has a premier Research Enterprise providing infrastructure, faculty mentoring and grant writing support. The University of Utah has a robust biotechnology and venture commercialization program.
HCI is an NCI -designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network ( NCCN ), supporting and fostering a vibrant cancer research enterprise in a highly collegial environment. HCI has an outstanding history of academic achievement and impact, a collaborative environment, and a commitment to excellence in patient care, research, teaching, and service. Our integrated health system and HCI’s participation in the ORIEN network of leading cancer centers provide outstanding opportunities for multidisciplinary collaborations in basic and translational laboratory-based cancer research, epidemiology and cancer biostatistics, as well as population-based studies of childhood cancers and outcomes. HCI has exceptional physical resources and recently completed a major expansion that includes a new 220,000 sq. ft. research building. In addition, the University of Utah and HCI are home to superb shared resources, such as the Utah Population Database with more than 16 million records linking genealogies, health records, and vital statistics. HCI and U of U Health provide access to state-of-the-art equipment and services through exceptional core facilities (see www.cores.utah.edu), including genomics/metabolomics/proteomics, a GMP -certified cell therapy and regenerative medicine facility, and a comprehensive biospecimen repository, which serve to enhance both discovery and translational science.
Qualified candidates must be Board Eligible/Board Certified in Pediatrics and Board Certified in Pediatric Hematology-Oncology. Additional clinical training and/or significant experience in leukemia/lymphoma or solid tumors/sarcomas is highly preferred. The selected candidate will receive a faculty appointment in the Department of Pediatrics on the Clinical or Tenure Track at the academic level commensurate with experience and qualifications.
Interested individuals can apply at https://utah.peopleadmin.com/postings/124810. Cover letter and curriculum vitae are required. For additional information about the position, please contact: Michael Pulsipher, M.D., at michael.pulsipher@hci.utah.edu.
The Department and University offers a competitive salary and an unmatched benefits program, including non-contributory retirement contributions of 20.2% of annual salary that vest immediately.
Salt Lake City offers an incredible quality of life with a growing economy, rich cultural scene with ballet, theatre, symphony, opera and museums, outstanding restaurants, and a moderate cost of living. The city is a well-known ski destination and a gateway to the state’s renowned landscapes. In addition to its 14 ski resorts, Utah boasts five scenic national parks (with five more within a day’s drive), a variety of golf courses allowing for year-round play, hundreds of miles of hiking and biking trails, a picturesque Lake Powell, and numerous other outdoor activities.
The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, diversity, integrity, quality, and trust that is integral to our mission.
EEO/Non-Discrimination Information
All qualified individuals are strongly encouraged to apply. Veterans’ preference is extended to qualified applicants, upon request and consistent with University policy and Utah state law. Upon request, reasonable accommodations in the application process will be provided to individuals with disabilities.
The University of Utah is an Affirmative Action/Equal Opportunity employer and does not discriminate based upon race, ethnicity, color, religion, national origin, age, disability, sex, sexual orientation, gender, gender identity, gender expression, pregnancy, pregnancy-related conditions, genetic information, or protected veteran’s status. The University does not discriminate on the basis of sex in the education program or activity that it operates, as required by Title IX and 34 CFR part 106. The requirement not to discriminate in education programs or activities extends to admission and employment. Inquiries about the application of Title IX and its regulations may be referred to the Title IX Coordinator, to the Department of Education, Office for Civil Rights, or both.
To request a reasonable accommodation for a disability or if you or someone you know has experienced discrimination or sexual misconduct including sexual harassment, you may contact the Director/Title IX Coordinator in the Office of Equal Opportunity and Affirmative Action ( OEO /AA). More information, including the Director/Title IX Coordinator’s office address, electronic mail address, and telephone number can be located at:
https://www.utah.edu/nondiscrimination/
Online reports may be submitted at oeo.utah.edu
Notice
The University is a participating employer with Utah Retirement Systems (“ URS ”). Eligible new hires with prior URS service, may elect to enroll in URS if they make the election before they become eligible for retirement (usually the first day of work). Contact Human Resources at (801) 581-7447 for information. Individuals who previously retired and are receiving monthly retirement benefits from URS are subject to URS’ post-retirement rules and restrictions. Please contact Utah Retirement Systems at (801) 366-7770 or (800) 695-4877 or University Human Resource Management at (801) 581-7447 if you have questions regarding the post-retirement rules.
This position may require the successful completion of a criminal background check and/or drug screen and immunizations. https://safety.utah.edu/safetyreport This report includes statistics about criminal offenses, hate crimes, arrests and referrals for disciplinary action, and Violence Against Women Act offenses. They also provide information about safety and security-related services offered by the University of Utah. A paper copy can be obtained by request at the Department of Public Safety located at 1658 East 500 South.
Special Instructions for Candidates
Open Date 10/28/2021
Close Date
Open Until Filled Yes
Requisition Number PRN02815F
Type Faculty
Position/Rank Pediatric Oncologist and Medical Director/Rank Dependent on Qualifications
Department 00857 - Pediatric Hematology/Oncology
City Salt Lake City, UT
Track Track Dependent on Qualifications
New Position to Begin CY2022 or later
Details
This is an outstanding opportunity to join a collegial academic environment at Primary Children’s Hospital ( PCH ) and the University of Utah with a childhood blood disorder and cancer program that U.S. News ranks among the top 20 in the nation. The Division of Pediatric Hematology Oncology, in the Department of Pediatrics, University of Utah School of Medicine, has an immediate opening for a board-certified Pediatric Hematologist/Oncologist, who will serve as the Medical Director of the Pediatric Hematopoietic Stem Cell Transplant and Cellular Therapy Program. This is an academic clinical leadership position with day-to-day responsibility for the operation of a busy clinical service. As a member of the division’s leadership team, the Director will lead a multidisciplinary team of pediatric hematology-oncology transplant and cellular therapy professionals managing blood disorders and cancer at PCH in the Pediatric Hematology/Oncology Service Line outpatient and inpatient units. The pediatric BMT physicians provide care to pediatric bone marrow transplant patients starting with initial consultation, preparation for and performance of the transplant process, and post-transplant care, including long-term follow-up. Clinical activities will be carried out at PCH . Active clinical programs include cellular and immune therapies and transplantation for hematologic malignancies, selected solid tumors, non-malignant disorders including bone marrow failure syndromes, immunodeficiencies, metabolic disorders and hemoglobinopathies. The BMT program directs an immune deficiency clinic that provides consultations, evaluations, and care to patients with immunodeficiencies. Active areas of research in the program include novel immune and cellular therapies, graft versus host disease, immunodeficiencies, and alternative stem cell transplants.
The Service-Line includes multi-disciplinary colleagues and investigators in Pediatric Hematology/Oncology, Transplantation and Cellular Therapy, and Radiation Oncology, along with additional services at the Huntsman Cancer Institute ( HCI ) and within the Department of Pediatrics. The Director will oversee and provide leadership in clinical, basic, and translational research programs, and will have the opportunity to implement early phase and investigator initiated clinical trials, as well as collaborations with established immunotherapy and cell therapy programs. The Director will also provide clinical patient care services. In addition to clinical service and research activities, there is an expectation for academic work, including education, investigation, administration, and advocacy.
This growing division is made up of more than 20 pediatric oncologists, including 4 pediatric BMT attendings, and 3 PhD investigators. In partnership with Pediatrics and PCH , the pediatric cancer research program at HCI is actively recruiting research scientists. The program has focused expertise in Oncology, Hematology, Transplantation and Cellular Therapy, Population Sciences, Cancer Control, and Pediatric Cancer Genetics. The program sees over 220 newly diagnosed children annually. It has consistently been in the top 10 enrolling COG institutions and is an active member of other national consortiums including PEP - CTN , PTCTC , TACL , POETIC , NANT , PNOC , and the Sunshine Network. The division houses the only pediatric BMT service in the Intermountain West, performs over 50 transplants annually, and has an active CAR T cell program. The Oncology section is made up of 14 physicians with varying levels of clinical, research, and programmatic leadership responsibility in the areas of leukemia/lymphoma, neuro-oncology, blastomas, and sarcomas. The inpatient unit has 33 private patient rooms where all hematology/oncology patients are admitted. Inpatients are overseen by 3 hematology/oncology services: an inpatient attending/resident/fellow hematology/oncology service, a chemotherapy attending/advanced practitioner service, and a BMT service with advanced practitioner support. All medical, pathology, radiologic and surgical subspecialties are represented in the children’s hospital.
PCH is ranked by US News in the top 20 childhood cancer programs, and provides care to children with cancer across the five-state Intermountain West region. The Department of Pediatrics ranks within the top 15 Pediatric Departments in NIH funding and has a premier Research Enterprise providing infrastructure, faculty mentoring and grant writing support. The University of Utah has a robust biotechnology and venture commercialization program.
HCI is an NCI -designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network ( NCCN ), supporting and fostering a vibrant cancer research enterprise in a highly collegial environment. HCI has an outstanding history of academic achievement and impact, a collaborative environment, and a commitment to excellence in patient care, research, teaching, and service. Our integrated health system and HCI’s participation in the ORIEN network of leading cancer centers provide outstanding opportunities for multidisciplinary collaborations in basic and translational laboratory-based cancer research, epidemiology and cancer biostatistics, as well as population-based studies of childhood cancers and outcomes. HCI has exceptional physical resources and recently completed a major expansion that includes a new 220,000 sq. ft. research building. In addition, the University of Utah and HCI are home to superb shared resources, such as the Utah Population Database with more than 16 million records linking genealogies, health records, and vital statistics. HCI and U of U Health provide access to state-of-the-art equipment and services through exceptional core facilities (see www.cores.utah.edu), including genomics/metabolomics/proteomics, a GMP -certified cell therapy and regenerative medicine facility, and a comprehensive biospecimen repository, which serve to enhance both discovery and translational science.
Qualified candidates must be Board Eligible/Board Certified in Pediatrics and Board Certified in Pediatric Hematology-Oncology. Additional clinical training and/or significant experience in leukemia/lymphoma or solid tumors/sarcomas is highly preferred. The selected candidate will receive a faculty appointment in the Department of Pediatrics on the Clinical or Tenure Track at the academic level commensurate with experience and qualifications.
Interested individuals can apply at https://utah.peopleadmin.com/postings/124810. Cover letter and curriculum vitae are required. For additional information about the position, please contact: Michael Pulsipher, M.D., at michael.pulsipher@hci.utah.edu.
The Department and University offers a competitive salary and an unmatched benefits program, including non-contributory retirement contributions of 20.2% of annual salary that vest immediately.
Salt Lake City offers an incredible quality of life with a growing economy, rich cultural scene with ballet, theatre, symphony, opera and museums, outstanding restaurants, and a moderate cost of living. The city is a well-known ski destination and a gateway to the state’s renowned landscapes. In addition to its 14 ski resorts, Utah boasts five scenic national parks (with five more within a day’s drive), a variety of golf courses allowing for year-round play, hundreds of miles of hiking and biking trails, a picturesque Lake Powell, and numerous other outdoor activities.
The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, diversity, integrity, quality, and trust that is integral to our mission.
EEO/Non-Discrimination Information
All qualified individuals are strongly encouraged to apply. Veterans’ preference is extended to qualified applicants, upon request and consistent with University policy and Utah state law. Upon request, reasonable accommodations in the application process will be provided to individuals with disabilities.
The University of Utah is an Affirmative Action/Equal Opportunity employer and does not discriminate based upon race, ethnicity, color, religion, national origin, age, disability, sex, sexual orientation, gender, gender identity, gender expression, pregnancy, pregnancy-related conditions, genetic information, or protected veteran’s status. The University does not discriminate on the basis of sex in the education program or activity that it operates, as required by Title IX and 34 CFR part 106. The requirement not to discriminate in education programs or activities extends to admission and employment. Inquiries about the application of Title IX and its regulations may be referred to the Title IX Coordinator, to the Department of Education, Office for Civil Rights, or both.
To request a reasonable accommodation for a disability or if you or someone you know has experienced discrimination or sexual misconduct including sexual harassment, you may contact the Director/Title IX Coordinator in the Office of Equal Opportunity and Affirmative Action ( OEO /AA). More information, including the Director/Title IX Coordinator’s office address, electronic mail address, and telephone number can be located at:
https://www.utah.edu/nondiscrimination/
Online reports may be submitted at oeo.utah.edu
Notice
The University is a participating employer with Utah Retirement Systems (“ URS ”). Eligible new hires with prior URS service, may elect to enroll in URS if they make the election before they become eligible for retirement (usually the first day of work). Contact Human Resources at (801) 581-7447 for information. Individuals who previously retired and are receiving monthly retirement benefits from URS are subject to URS’ post-retirement rules and restrictions. Please contact Utah Retirement Systems at (801) 366-7770 or (800) 695-4877 or University Human Resource Management at (801) 581-7447 if you have questions regarding the post-retirement rules.
This position may require the successful completion of a criminal background check and/or drug screen and immunizations. https://safety.utah.edu/safetyreport This report includes statistics about criminal offenses, hate crimes, arrests and referrals for disciplinary action, and Violence Against Women Act offenses. They also provide information about safety and security-related services offered by the University of Utah. A paper copy can be obtained by request at the Department of Public Safety located at 1658 East 500 South.
Special Instructions for Candidates
Open Date 10/28/2021
Close Date
Open Until Filled Yes
Requisition Number PRN02815F
Type Faculty